重塑全球药企版图!阿斯利康(AZN.US)拟洽购百时美施贵宝(BMY.US),或缔造史上最大医药并购案

智通财经
Aug 03
【重塑全球药企版图!阿斯利康(AZN.US)拟洽购百时美施贵宝(BMY.US),或缔造史上最大医药并购案】智通财经APP获悉,据知情人士透露,阿斯利康(AZN.US)已就收购百时美施贵宝(BMY.US)展开探讨,这桩超级交易若达成,将缔造全球规模最大的制药企业之一。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10